• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用密炼机转矩流变仪预测挤出/滚圆法制粒的最佳湿法制粒参数。

Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization.

作者信息

Ibrahim Mohamed A, Zayed Gamal M, Alsharif Fahd M, Abdelhafez Wael A

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.

出版信息

Saudi Pharm J. 2019 Feb;27(2):182-190. doi: 10.1016/j.jsps.2018.10.002. Epub 2018 Oct 19.

DOI:10.1016/j.jsps.2018.10.002
PMID:30766428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6362277/
Abstract

In this study, we aimed to optimize theophylline pellet formulations using a two-factor three-level full-factorial design (3) by monitoring the concentration of two pellet excipients, polyvinyl pyrrolidone K30 (PVP) binder solution (X1) and the hydrophilic excipient mannitol (X2). Their impact on pellet characteristics (responses) were evaluated. Increasing PVP concentration in the binder solution resulted in an increase in the wet mass torque value. The effect of mannitol, however, was antagonistic. Moreover, the pellet particle size was significantly influenced by the level of mannitol, PVP solution, and quadratic effect of mannitol. Mannitol significantly antagonized the pellet particle size. Furthermore, increased mannitol concentrations significantly enhanced drug dissolution rate from the pellets, whereas PVP concentration in the binder solution significantly reduced the drug dissolution rate. In conclusion, wet granulations can be controlled by monitoring the composition of the binder solution and pellet composition.

摘要

在本研究中,我们旨在通过监测两种微丸辅料(聚乙烯吡咯烷酮K30(PVP)粘合剂溶液(X1)和亲水性辅料甘露醇(X2))的浓度,采用二因素三水平全因子设计(3)来优化茶碱微丸制剂。评估了它们对微丸特性(响应)的影响。粘合剂溶液中PVP浓度的增加导致湿质量扭矩值增加。然而,甘露醇的影响是拮抗的。此外,微丸粒径受甘露醇水平、PVP溶液以及甘露醇的二次效应显著影响。甘露醇显著拮抗微丸粒径。此外,甘露醇浓度的增加显著提高了微丸的药物溶出速率,而粘合剂溶液中PVP浓度则显著降低了药物溶出速率。总之,通过监测粘合剂溶液的组成和微丸组成可以控制湿法制粒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/3249da9cf52c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/b16560144731/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/69174e7b1e50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/7a3d697a716d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/687f085ddd04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/3249da9cf52c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/b16560144731/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/69174e7b1e50/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/7a3d697a716d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/687f085ddd04/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bde/6362277/3249da9cf52c/gr5.jpg

相似文献

1
Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization.利用密炼机转矩流变仪预测挤出/滚圆法制粒的最佳湿法制粒参数。
Saudi Pharm J. 2019 Feb;27(2):182-190. doi: 10.1016/j.jsps.2018.10.002. Epub 2018 Oct 19.
2
Formulation and evaluation of mefenamic acid sustained release matrix pellets.甲芬那酸缓释骨架微丸的制备与评价。
Acta Pharm. 2013 Mar;63(1):85-98. doi: 10.2478/acph-2013-0009.
3
Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations.结冷胶和聚乙烯吡咯烷酮(PVP)作为挤出/滚圆制粒配方中的黏合剂。
Acta Pharm. 2019 Mar 1;69(1):99-109. doi: 10.2478/acph-2019-0007.
4
Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization.通过挤出/滚圆法制备的基于Eudragit-RL-100的醋氯芬酸缓释骨架微丸的研制与表征
Polymers (Basel). 2021 Nov 21;13(22):4034. doi: 10.3390/polym13224034.
5
Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration.以挤出滚圆法制备的 Eudragit RS 布洛芬微丸的制备、表征和释放特性:黏合剂类型和浓度的影响。
Drug Dev Ind Pharm. 2013 Aug;39(8):1238-46. doi: 10.3109/03639045.2012.707207. Epub 2012 Aug 9.
6
Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.使用混合器扭矩流变仪预测药物微丸挤出滚圆法的最佳湿法制粒参数。
Int J Pharm. 2017 Jan 30;517(1-2):19-24. doi: 10.1016/j.ijpharm.2016.11.057. Epub 2016 Nov 30.
7
Use of extrusion aids for successful production of Kollidon CL-SF pellets by extrusion-spheronization.挤出助剂在挤出滚圆法制备交聚维酮 Kollidon® CL-SF 丸中的应用。
Drug Dev Ind Pharm. 2018 Apr;44(4):632-642. doi: 10.1080/03639045.2017.1405975. Epub 2017 Dec 7.
8
In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.通过挤出/滚圆法制备的肠溶包衣淀粉基微丸的体外和体内评价
Eur J Pharm Biopharm. 2008 Sep;70(1):302-12. doi: 10.1016/j.ejpb.2008.04.019. Epub 2008 Apr 29.
9
Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets: studies.赖诺普利粘膜粘附缓释骨架微丸的优化与评价:研究
Saudi Pharm J. 2023 Aug;31(8):101690. doi: 10.1016/j.jsps.2023.06.023. Epub 2023 Jun 28.
10
The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.液体粘合剂对液体流动性以及通过挤出/滚圆法制备球形颗粒的影响。
Int J Pharm. 2002 May 15;238(1-2):61-76. doi: 10.1016/s0378-5173(02)00064-9.

引用本文的文献

1
Croscarmellose Sodium as Pelletization Aid in Extrusion-Spheronization.交联羧甲纤维素钠作为挤出滚圆制粒中的助流剂。
AAPS PharmSciTech. 2024 Jun 27;25(6):147. doi: 10.1208/s12249-024-02864-0.
2
Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets: studies.赖诺普利粘膜粘附缓释骨架微丸的优化与评价:研究
Saudi Pharm J. 2023 Aug;31(8):101690. doi: 10.1016/j.jsps.2023.06.023. Epub 2023 Jun 28.
3
Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization.

本文引用的文献

1
Formation of mannitol core microparticles for sustained release with lipid coating in a mini fluid bed system.在小型流化床系统中,用脂质包衣形成甘露醇核心微球以实现缓释。
Eur J Pharm Biopharm. 2017 Nov;120:126-132. doi: 10.1016/j.ejpb.2017.09.003. Epub 2017 Sep 8.
2
Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.用于难溶性止吐剂盐酸美克洛嗪缓释的脂质载挤出滚圆颗粒。
Lipids Health Dis. 2017 Apr 12;16(1):75. doi: 10.1186/s12944-017-0466-x.
3
Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.
通过挤出/滚圆法制备的基于Eudragit-RL-100的醋氯芬酸缓释骨架微丸的研制与表征
Polymers (Basel). 2021 Nov 21;13(22):4034. doi: 10.3390/polym13224034.
使用混合器扭矩流变仪预测药物微丸挤出滚圆法的最佳湿法制粒参数。
Int J Pharm. 2017 Jan 30;517(1-2):19-24. doi: 10.1016/j.ijpharm.2016.11.057. Epub 2016 Nov 30.
4
Upgrading wet granulation monitoring from hand squeeze test to mixing torque rheometry.从手挤压测试到混合扭矩流变仪对湿法造粒监测进行升级。
Saudi Pharm J. 2012 Jan;20(1):9-19. doi: 10.1016/j.jsps.2011.04.007. Epub 2011 May 7.
5
Formulation and evaluation of mefenamic acid sustained release matrix pellets.甲芬那酸缓释骨架微丸的制备与评价。
Acta Pharm. 2013 Mar;63(1):85-98. doi: 10.2478/acph-2013-0009.
6
The rheological properties of modified microcrystalline cellulose containing high levels of model drugs.含有高剂量模型药物的改性微晶纤维素的流变学性质。
J Pharm Sci. 2009 Jun;98(6):2160-9. doi: 10.1002/jps.21587.
7
Torque rheological parameters to predict pellet quality in extrusion-spheronization.用于预测挤出滚圆法中微丸质量的扭矩流变学参数
Int J Pharm. 2006 Jun 6;315(1-2):99-109. doi: 10.1016/j.ijpharm.2006.02.023. Epub 2006 Mar 6.
8
Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.微晶纤维素等级和工艺变量对挤出滚圆法制备微丸的影响。
Drug Dev Ind Pharm. 2002 Apr;28(4):451-6. doi: 10.1081/ddc-120003006.
9
Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.一种新型美托洛尔多单元控释制剂——美托洛尔缓释片的设计
Eur J Clin Pharmacol. 1988;33 Suppl:S3-7. doi: 10.1007/BF00578405.